Zhejiang Lanyu Digital Technology
301585
BBK Test Systems
301598
Youkeshu Technology
300209
Feitian Technologies
300386
Minami Acoustics
301383
CN Stock MarketDetailed Quotes
600332 Guangzhou Baiyunshan Pharmaceutical Holdings
- 29.14
- +0.25+0.87%
Trading Dec 20 13:17 CST
47.38BMarket Cap13.84P/E (TTM)
29.20High28.79Low32.65KlotVolume28.88Open28.89Pre Close94.86MTurnover0.23%Turnover Ratio11.68P/E (Static)1.63BShares33.3252wk High1.31P/B40.97BFloat Cap23.9052wk Low31.78Limit Up1.41BShs Float43.10Historical High26.00Limit Down1.42%Amplitude-2.19Historical Low1.15Dividend TTM29.06Avg Price12.35KlotAsk3.94%Div YieldTTM100Lot Size19.75KlotBid
Guangzhou Baiyunshan Pharmaceutical Holdings Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 1.50%59.06B | 2.68%41.04B | 6.09%22.95B | 6.68%75.52B | 6.16%58.18B | 7.39%39.97B | 5.31%21.63B | 2.57%70.79B | 2.37%54.81B | 3.02%37.22B |
| Operating revenue | 1.50%59.06B | 2.68%41.04B | 6.09%22.95B | 6.68%75.52B | 6.16%58.18B | 7.39%39.97B | 5.31%21.63B | 2.57%70.79B | 2.37%54.81B | 3.02%37.22B |
| Other operating revenue | ---- | -25.05%103.17M | ---- | 1.08%240.53M | ---- | 0.59%137.66M | ---- | -7.08%237.96M | ---- | 13.28%136.84M |
| Total operating cost | 3.03%55.41B | 3.91%38.08B | 6.90%20.67B | 6.61%70.96B | 5.98%53.78B | 7.02%36.64B | 5.57%19.33B | 2.70%66.56B | 2.57%50.74B | 3.63%34.24B |
| Operating cost | 4.49%48.6B | 5.05%33.24B | 7.68%17.87B | 6.64%61.33B | 5.79%46.51B | 7.22%31.65B | 5.68%16.59B | 3.10%57.51B | 2.96%43.97B | 3.21%29.52B |
| Operating tax surcharges | -5.49%235.36M | -3.33%168.05M | 0.60%100.86M | 15.62%344.16M | 9.81%249.02M | 8.92%173.85M | -1.93%100.26M | -0.06%297.66M | -4.32%226.77M | -1.69%159.61M |
| Operating expense | -10.13%4.23B | -4.40%3.12B | 1.21%1.89B | 3.90%6.1B | 5.51%4.71B | 2.42%3.26B | -0.40%1.87B | -1.33%5.88B | -2.42%4.46B | 6.19%3.19B |
| Administration expense | -0.76%1.76B | 1.12%1.21B | 2.34%644.08M | 9.16%2.42B | 11.89%1.77B | 12.31%1.2B | 20.06%629.33M | 9.15%2.22B | 7.86%1.58B | 10.10%1.07B |
| Financial expense | 104.66%2.04M | -50.37%-59.67M | 43.52%-19.91M | 87.96%-19.56M | 73.09%-43.84M | 69.34%-39.68M | 72.31%-35.25M | -22.14%-162.46M | -38.05%-162.94M | -76.02%-129.43M |
| -Interest expense (Financial expense) | -4.66%317.47M | -5.37%213.35M | -4.74%106.43M | 2.71%446.19M | 7.32%333.01M | 8.41%225.45M | 4.97%111.73M | 3.97%434.41M | 0.35%310.29M | 2.04%207.96M |
| -Interest Income (Financial expense) | 16.63%-323.77M | -2.65%-278.16M | 14.12%-128.17M | 22.41%-486.34M | 21.49%-388.34M | 23.63%-270.97M | 36.76%-149.25M | -11.16%-626.79M | -11.26%-494.63M | -24.06%-354.82M |
| Research and development | -0.17%578.51M | -2.35%391.15M | 3.76%186.14M | -4.55%782.14M | -12.78%579.48M | -9.23%400.57M | -24.90%179.39M | -6.32%819.45M | 9.87%664.39M | 14.36%441.32M |
| Credit Impairment Loss | 36.63%-87.86M | 18.27%-82.13M | 7.04%-69.04M | -84.17%-83.14M | -201.01%-138.65M | -389.23%-100.49M | -207.54%-74.27M | 58.89%-45.15M | -12.40%-46.06M | 44.45%-20.54M |
| Asset Impairment Loss | -229.30%-4.79M | -132.73%-1.32M | -379.50%-7.22M | 55.90%-3.52M | 129.13%3.7M | 400.25%4.02M | 74.95%-1.51M | 32.68%-7.98M | 14.36%-12.71M | 89.82%-1.34M |
| Other net revenue | -0.01%350.34M | 25.94%259.15M | 202.93%172.71M | -32.99%566.63M | -11.79%350.36M | -41.60%205.77M | 56.58%57.01M | 45.95%845.57M | 105.85%397.2M | 120.86%352.33M |
| Fair value change income | 31.79%28.11M | -98.99%445.75K | -41.05%8.24M | 1,175.97%38.64M | 491.21%21.33M | 4,726.36%44.05M | -41.95%13.98M | -101.82%-3.59M | 43.61%-5.45M | 84.69%-952.23K |
| Invest income | -25.80%191.4M | -10.75%157.45M | 24.95%102.12M | -37.12%264.84M | 152.69%257.94M | 218.71%176.42M | 290.96%81.73M | 117.56%421.17M | -35.24%102.08M | -59.77%55.36M |
| -Including: Investment income associates | -120.20%-19.32M | -84.58%11.11M | -35.00%23.55M | -21.01%107.89M | 15.80%95.62M | 7.99%72.05M | 19.37%36.23M | 11.09%136.59M | -46.43%82.57M | -48.16%66.72M |
| Asset deal income | -52.07%733.1K | -33.40%293K | -93.60%23.28K | 1,643.51%12.03M | 73.40%1.53M | -20.73%439.94K | 4,114.74%363.93K | -0.68%689.82K | -52.53%881.98K | 347.60%554.97K |
| Other revenue | 8.92%222.75M | 126.76%184.41M | 277.48%138.59M | -29.69%337.78M | -42.95%204.51M | -74.53%81.32M | 70.18%36.71M | 55.04%480.42M | 262.18%358.47M | 308.50%319.25M |
| Operating profit | -15.88%4B | -8.69%3.23B | 4.23%2.45B | 0.92%5.12B | 6.61%4.76B | 6.04%3.53B | 3.97%2.35B | 6.02%5.07B | 4.67%4.46B | 2.67%3.33B |
| Add:Non operating Income | 101.64%28.09M | 70.34%15.61M | -12.70%4.28M | 61.57%29.28M | 3.24%13.93M | -4.66%9.16M | 1.39%4.9M | -60.01%18.12M | -20.78%13.49M | -18.17%9.61M |
| Less:Non operating expense | 30.19%23.12M | 26.01%12.3M | 56.63%4.19M | -19.48%39.67M | -0.40%17.76M | 4.15%9.76M | -30.83%2.67M | -54.49%49.28M | -76.03%17.83M | -86.16%9.37M |
| Total profit | -15.71%4.01B | -8.59%3.23B | 4.13%2.45B | 1.33%5.11B | 6.63%4.75B | 6.02%3.53B | 4.03%2.35B | 6.78%5.04B | 5.99%4.46B | 4.48%3.33B |
| Less:Income tax cost | -13.00%716.6M | -8.11%561.37M | 8.99%420.62M | 7.76%851.17M | 6.67%823.71M | 4.74%610.95M | 3.68%385.93M | 4.75%789.87M | 10.97%772.22M | 8.06%583.3M |
| Net profit | -16.27%3.29B | -8.68%2.67B | 3.18%2.03B | 0.14%4.26B | 6.62%3.93B | 6.29%2.92B | 4.10%1.97B | 7.17%4.25B | 5.00%3.68B | 3.75%2.75B |
| Net profit from continuing operation | -16.27%3.29B | -8.68%2.67B | 3.18%2.03B | 0.14%4.26B | 6.62%3.93B | 6.29%2.92B | 4.10%1.97B | 7.17%4.25B | 5.00%3.68B | 3.75%2.75B |
| Less:Minority Profit | -5.10%130.46M | 7.21%118.47M | 21.76%73.61M | -29.00%203.65M | -34.65%137.48M | -30.48%110.49M | -29.63%60.45M | 15.15%286.85M | 6.55%210.37M | 8.03%158.94M |
| Net profit of parent company owners | -16.68%3.16B | -9.31%2.55B | 2.59%1.96B | 2.25%4.06B | 9.12%3.79B | 8.54%2.81B | 5.70%1.91B | 6.63%3.97B | 4.91%3.47B | 3.50%2.59B |
| Earning per share | ||||||||||
| Basic earning per share | -16.68%1.943 | -9.31%1.568 | 2.56%1.204 | 2.25%2.495 | 9.12%2.332 | 8.54%1.729 | 5.67%1.174 | 6.64%2.44 | 4.91%2.137 | 3.51%1.593 |
| Diluted earning per share | -16.68%1.943 | -9.31%1.568 | 2.56%1.204 | 2.25%2.495 | 9.12%2.332 | 8.54%1.729 | 5.67%1.174 | 6.64%2.44 | 4.91%2.137 | 3.51%1.593 |
| Other composite income | 180.47%5.45M | 1,146.49%5.25M | 125.27%1.51M | -311.79%-12.23M | -172.36%-6.77M | -111.02%-501.35K | -307.39%-5.96M | 4,426.36%5.78M | 1,405.31%9.36M | 199.34%4.55M |
| Other composite income of parent company owners | 179.37%4.94M | 1,373.89%4.98M | 124.43%1.44M | -350.11%-11.44M | -168.17%-6.23M | -107.28%-390.85K | -423.18%-5.88M | 2,220.88%4.58M | 703.23%9.13M | 232.67%5.37M |
| Other composite income of minority owners | 192.97%509.89K | 342.18%267.61K | 185.91%70.22K | -165.73%-788.84K | -339.41%-548.45K | 86.44%-110.5K | 75.92%-81.74K | 1,825.81%1.2M | -71.25%229.09K | -51.89%-814.78K |
| Total composite income | -15.99%3.29B | -8.49%2.67B | 3.57%2.03B | -0.28%4.25B | 6.17%3.92B | 6.09%2.92B | 3.86%1.96B | 7.31%4.26B | 5.29%3.69B | 4.10%2.75B |
| Total composite income of parent company owners | -16.41%3.16B | -9.12%2.55B | 2.99%1.96B | 1.84%4.04B | 8.66%3.79B | 8.30%2.81B | 5.44%1.9B | 6.75%3.97B | 5.23%3.48B | 3.88%2.6B |
| Total composite income of minority owners | -4.35%130.97M | 7.56%118.73M | 22.04%73.68M | -29.57%202.86M | -34.98%136.93M | -30.19%110.38M | -29.44%60.37M | 15.66%288.05M | 6.24%210.59M | 7.87%158.12M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
